Anicteric veno-occlusive disease after hematopoietic stem cell transplantation in children

Jeffrey Naples(Nationwide Children's Hospital), Rajinder S. Bajwa(Nationwide Children's Hospital), Edwin M. Horwitz(St. Jude Children's Research Hospital), Micah Skeens(The Ohio State University), Rolla Abu‐Arja(Nationwide Children's Hospital), Jeffery J. Auletta(Nationwide Children's Hospital), Hemalatha G. Rangarajan(Nationwide Children's Hospital), Joseph Stanek(Nationwide Children's Hospital)
Bone Marrow Transplantation
September 14, 2015
10.1038/bmt.2015.208
Cited by 32

Related Papers

Early cytomegalovirus reactivation remains associated with increased transplant-related mortality in the current era: a CIBMTR analysis
|Blood|2016|554
COVID-19 in immunocompromised patients: A systematic review of cancer, hematopoietic cell and solid organ transplant patients
|Journal of Infection|2021|248
Animal serum-free culture conditions for isolation and expansion of multipotent mesenchymal stromal cells from human BM
|Cytotherapy|2006|245
Adipose-Derived Mesenchymal Stem Cells as Stable Source of Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand Delivery for Cancer Therapy
|Cancer Research|2010|244
Posttransplant cyclophosphamide is associated with increased cytomegalovirus infection: a CIBMTR analysis
|Blood|2021|180